Can Epstein–Barr virus‐deoxyribonucleic acid load after induction chemotherapy combined with American Joint Committee on Cancer stage determine the chemotherapy intensity of locally advanced nasopharyngeal carcinoma?

BACKGROUND: Induction chemotherapy (IC) comprising docetaxel, cisplatin, and fluorouracil (TPF), combined with concurrent chemoradiotherapy (CCRT) effectively improves the survival rate of locally advanced nasopharyngeal carcinoma (LA‐NPC). Selecting patients whose risk of tumor recurrence and metas...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Qun, Peng, Zhen‐Wei, Gu, Zhuo‐Sheng, Wang, Yan, He, Fang, Zhao, Wen‐Bin, Luo, Wei, Mei, Yong‐Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844613/
https://www.ncbi.nlm.nih.gov/pubmed/35674137
http://dx.doi.org/10.1002/cam4.4899

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9844613/
https://www.ncbi.nlm.nih.gov/pubmed/35674137
http://dx.doi.org/10.1002/cam4.4899

Ejemplares similares